• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Genetics Market
    Genetics News
    Genetics Stocks
    • Genetics Market
    • Genetics News
    • Genetics Stocks

    LifeLabs Offers Better Access to Canadian-Based Prenatal Screening Test

    Vivien Diniz
    Jan. 21, 2016 09:49AM PST
    Genetics Investing

    LifeLabs reported that expectant mothers all across Canada are taking advantage of improved access to a simple blood test.

    LifeLabs reported that expectant mothers all across Canada are taking advantage of improved access to a simple blood test that can provide important information about their pregnancy, including if their baby is at risk for fetal problems and genetic conditions, at as early as nine weeks gestation.
    According to the press release:

    The Panorama Non-Invasive Prenatal Test (NIPT) is the most accurate prenatal test available and has been performed by LifeLabs Medical Laboratory Services (“LifeLabs”) at its genetics lab in Toronto since October 2015. LifeLabs is the first Canadian laboratory to perform NIPT in Canada, which can decrease the need for invasive tests like amniocentesis in many pregnancies.

    Sue Paish President and CEO of LifeLabs commented:

    Since beginning to offer the test in October, interest and uptake by healthcare professionals and their patients has been tremendous. In less than three months LifeLabs is now performing the pre-natal test for expectant mothers in all ten provinces. By conducting this test in Canada, Canadians have better access to the test and are receiving results faster. Our healthcare system is also realizing meaningful savings.

    Click here to view the full press release.
     

    canada
    The Conversation (0)

    Go Deeper

    AI Powered
    liquid sample testing vials in a lab

    5 Genetic Testing Stocks

    Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations

    Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×